Search Results

Results 1 - 10 From 292

Filter options

humandiagnostik (292)

2 (6)
3 infection using IgA antibodies in human serum or plasma in the general population. The semi-quantitative manual assay is designed for professional use in a laborato (1)
3 infection using IgA antibodies in human serum or plasma in the general population. The semi-quantitative semi-automated assay is designed for professional use in a l (1)
3 infection using IgG antibodies in human serum or plasma in the general population. The semi-quantitative manual assay is designed for professional use in a laborato (1)
3 infection using IgG antibodies in human serum or plasma in the general population. The semi-quantitative semi-automated assay is designed for professional use in a l (1)
3 infection using IgM antibodies in human serum or plasma in the general population. The semi-quantitative manual assay is designed for professional use in a laborato (1)
3 infection using IgM antibodies in human serum or plasma in the general population. The semi-quantitative semi-automated assay is designed for professional use in a l (1)
The Microblot-Array assay is intended for the diagnosis of Bordetella pertussis and Bordetella parapertussis infection using IgA antibodies in human serum or plasma in the general population. The qualitative (1)
The Microblot-Array assay is intended for the diagnosis of Bordetella pertussis and Bordetella parapertussis infection using IgG antibodies in human serum or plasma in the general population. The qualitative (1)
The Microblot-Array assay is intended for the diagnosis of Bordetella pertussis and Bordetella parapertussis infection using IgM antibodies in human serum or plasma in the general population. The qualitative (1)
The Microblot-Array assay is intended for the diagnosis of Borrelia spp. and Anaplasma phagocytophilum infections using IgG antibodies in human serum (1)
The Microblot-Array assay is intended for the diagnosis of Borrelia spp. and Anaplasma phagocytophilum infections using IgM antibodies in human serum (1)
The Microblot-Array assay is intended for the diagnosis of Chlamydia spp. infection using IgA antibodies in human serum or plasma in the general population. The qualitative (1)
The Microblot-Array assay is intended for the diagnosis of Chlamydia spp. infection using IgG antibodies in human serum or plasma in the general population. The qualitative (1)
The Microblot-Array assay is intended for the diagnosis of EBV infection using IgA antibodies to recombinant antigens in human serum or plasma in the general population. The qualitative (1)
The Microblot-Array assay is intended for the diagnosis of EBV infection using IgG antibodies to recombinant antigens in human serum or plasma in the general population. The qualitative (1)
The Microblot-Array assay is intended for the diagnosis of EBV infection using IgM antibodies to recombinant antigens in human serum or plasma in the general population. The qualitative (1)
The Microblot-Array assay is intended for the diagnosis of Helicobacter pylori infection using IgA antibodies in human serum or plasma in the general population. The qualitative (1)
The Microblot-Array assay is intended for the diagnosis of Helicobacter pylori infection using IgG antibodies in human serum or plasma in the general population. The qualitative (1)
The Microblot-Array assay is intended for the diagnosis of Mycoplasma pneumoniae infection using IgA antibodies in human serum or plasma in the general population. The qualitative (1)
The Microblot-Array assay is intended for the diagnosis of Mycoplasma pneumoniae infection using IgG antibodies in human serum or plasma in the general population. The qualitative (1)
The Microblot-Array assay is intended for the diagnosis of Mycoplasma pneumoniae infection using IgM antibodies in human serum or plasma in the general population. The qualitative (1)
The Microblot-Array assay is intended for the diagnosis of Yersinia enterocolitica infection using IgA antibodies in human serum or plasma in the general population. The qualitative (1)
The Microblot-Array assay is intended for the diagnosis of Yersinia enterocolitica infection using IgG antibodies in human serum or plasma in the general population. The qualitative (1)
The Microblot-Array assay is intended for the diagnosis of systemic autoimmune diseases using IgG antibodies to extractable nuclear antigens in human serum or plasma in the general population. The qualitative (1)
The immunoblot assay is intended for the diagnosis of Anaplasma phagocytophilum infection using IgG antibodies in human serum or plasma in the general population. The qualitative and semi-quantitative manual assay is designed for professional use in a lab (1)
The immunoblot assay is intended for the diagnosis of Anaplasma phagocytophilum infection using IgM antibodies in human serum or plasma in the general population. The qualitative and semi-quantitative manual assay is designed for professional use in a lab (1)
The immunoblot assay is intended for the diagnosis of Bordetella pertussis and Bordetella parapertussis infection using IgA antibodies in human serum or plasma in the general population. The qualitative and semi-quantitative manual assay is designed for p (1)
The immunoblot assay is intended for the diagnosis of Bordetella pertussis and Bordetella parapertussis infection using IgG antibodies in human serum or plasma in the general population. The qualitative and semi-quantitative manual assay is designed for p (1)
The immunoblot assay is intended for the diagnosis of Bordetella pertussis and Bordetella parapertussis infection using IgM antibodies in human serum or plasma in the general population. The qualitative and semi-quantitative manual assay is designed for p (1)
The immunoblot assay is intended for the diagnosis of Borrelia spp. and Anaplasma phagocytophilum infections using IgG antibodies in human serum (1)
The immunoblot assay is intended for the diagnosis of Borrelia spp. and Anaplasma phagocytophilum infections using IgM antibodies in human serum (1)
The immunoblot assay is intended for the diagnosis of CMV infection using IgG antibodies in human serum or plasma in the general population. The qualitative and semi-quantitative manual assay is designed for professional use in a laboratory. (1)
The immunoblot assay is intended for the diagnosis of CMV infection using IgM antibodies in human serum or plasma in the general population. The qualitative and semi-quantitative manual assay is designed for professional use in a laboratory. (1)
The immunoblot assay is intended for the diagnosis of Chlamydia pneumoniae infection using IgA antibodies in human serum or plasma in the general population. The qualitative and semi-quantitative manual assay is designed for professional use in a laborato (1)
The immunoblot assay is intended for the diagnosis of Chlamydia pneumoniae infection using IgG antibodies in human serum or plasma in the general population. The qualitative and semi-quantitative manual assay is designed for professional use in a laborato (1)
The immunoblot assay is intended for the diagnosis of Chlamydia spp. infection using IgA antibodies in human serum or plasma in the general population. The qualitative and semi-quantitative manual assay is designed for professional use in a laboratory. (1)
The immunoblot assay is intended for the diagnosis of Chlamydia spp. infection using IgG antibodies in human serum or plasma in the general population. The qualitative and semi-quantitative manual assay is designed for professional use in a laboratory. (1)
The immunoblot assay is intended for the diagnosis of Chlamydia trachomatis infection using IgA antibodies in human serum or plasma in the general population. The qualitative and semi-quantitative manual assay is designed for professional use in a laborat (1)
The immunoblot assay is intended for the diagnosis of Chlamydia trachomatis infection using IgG antibodies in human serum or plasma in the general population. The qualitative and semi-quantitative manual assay is designed for professional use in a laborat (1)
The immunoblot assay is intended for the diagnosis of EBV infection using IgA antibodies to recombinant antigens in human serum or plasma in the general population. The qualitative and semi-quantitative manual assay is designed for professional use in a l (1)
The immunoblot assay is intended for the diagnosis of EBV infection using IgG antibodies to recombinant antigens in human serum or plasma in the general population. The qualitative and semi-quantitative manual assay is designed for professional use in a l (1)
The immunoblot assay is intended for the diagnosis of EBV infection using IgM antibodies to recombinant antigens in human serum or plasma in the general population. The qualitative and semi-quantitative manual assay is designed for professional use in a l (1)
The immunoblot assay is intended for the diagnosis of Helicobacter pylori infection using IgA antibodies in human serum or plasma in the general population. The qualitative and semi-quantitative manual assay is designed for professional use in a laborator (1)
The immunoblot assay is intended for the diagnosis of Helicobacter pylori infection using IgG antibodies in human serum or plasma in the general population. The qualitative and semi-quantitative manual assay is designed for professional use in a laborator (1)
The immunoblot assay is intended for the diagnosis of Mycoplasma pneumoniae infection using IgA antibodies in human serum or plasma in the general population. The qualitative and semi-quantitative manual assay is designed for professional use in a laborat (1)
The immunoblot assay is intended for the diagnosis of Mycoplasma pneumoniae infection using IgG antibodies in human serum or plasma in the general population. The qualitative and semi-quantitative manual assay is designed for professional use in a laborat (1)
The immunoblot assay is intended for the diagnosis of Mycoplasma pneumoniae infection using IgM antibodies in human serum or plasma in the general population. The qualitative and semi-quantitative manual assay is designed for professional use in a laborat (1)
The immunoblot assay is intended for the diagnosis of Toxoplasma gondii infection using IgA antibodies in human serum or plasma in the general population. The qualitative and semi-quantitative manual assay is designed for professional use in a laboratory. (1)
The immunoblot assay is intended for the diagnosis of Toxoplasma gondii infection using IgG antibodies in human serum or plasma in the general population. The qualitative and semi-quantitative manual assay is designed for professional use in a laboratory. (1)
The immunoblot assay is intended for the diagnosis of Toxoplasma gondii infection using IgM antibodies in human serum or plasma in the general population. The qualitative and semi-quantitative manual assay is designed for professional use in a laboratory. (1)
The immunoblot assay is intended for the diagnosis of Treponema pallidum infection using IgG antibodies in human serum or plasma in the general population. The qualitative and semi-quantitative manual assay is designed for professional use in a laboratory (1)
The immunoblot assay is intended for the diagnosis of Treponema pallidum infection using IgM antibodies in human serum or plasma in the general population. The qualitative and semi-quantitative manual assay is designed for professional use in a laboratory (1)
The immunoblot assay is intended for the diagnosis of Yersinia spp. infection using IgA antibodies in human serum or plasma in the general population. The qualitative and semi-quantitative manual assay is designed for professional use in a laboratory. (1)
The immunoblot assay is intended for the diagnosis of Yersinia spp. infection using IgG antibodies in human serum or plasma in the general population. The qualitative and semi-quantitative manual assay is designed for professional use in a laboratory. (1)
The immunoblot assay is intended for the diagnosis of Yersinia spp. infection using IgM antibodies in human serum or plasma in the general population. The qualitative and semi-quantitative manual assay is designed for professional use in a laboratory. (1)
The immunoblot assay is intended for the diagnosis of systemic autoimmune diseases using IgG antibodies to neutrophil cytoplasm and GBM in human serum or plasma in the general population. The qualitative and semi-quantitative manual assay is designed for (1)
The immunoblot assay is intended for the diagnosis of systemic autoimmune diseases using IgG antibodies to nuclear antigens in human serum or plasma in the general population. The qualitative and semi-quantitative manual assay is designed for professional (1)
The immunoenzymatic assay is intended for the diagnosis (14)
The immunoenzymatic assay is intended for the diagnosis CMV infection using IgA antibodies in human serum (1)
The immunoenzymatic assay is intended for the diagnosis CMV infection using IgM antibodies in human serum (1)
The immunoenzymatic assay is intended for the diagnosis and monitoring of Borrelia afzelii infection using IgG antibodies in human serum (2)
The immunoenzymatic assay is intended for the diagnosis and monitoring of Borrelia afzelii infection using IgM antibodies in human serum (2)
The immunoenzymatic assay is intended for the diagnosis and monitoring of Borrelia burgdorferi infection using IgG antibodies in human serum (2)
The immunoenzymatic assay is intended for the diagnosis and monitoring of Borrelia burgdorferi infection using IgM antibodies in human serum (2)
The immunoenzymatic assay is intended for the diagnosis and monitoring of Borrelia burgdorferi sensu lato infection using IgG antibodies in human serum (1)
The immunoenzymatic assay is intended for the diagnosis and monitoring of Borrelia burgdorferi sensu lato infection using IgM antibodies in human serum (1)
The immunoenzymatic assay is intended for the diagnosis and monitoring of Borrelia garinii infection using IgG antibodies in human serum (2)
The immunoenzymatic assay is intended for the diagnosis and monitoring of Borrelia garinii infection using IgM antibodies in human serum (2)
The immunoenzymatic assay is intended for the diagnosis and monitoring of Helicobacter pylori infection using IgA antibodies in human serum or plasma in the general population. The semi-quantitative and quantitative manual assay is designed for profession (1)
The immunoenzymatic assay is intended for the diagnosis and monitoring of Helicobacter pylori infection using IgA antibodies in human serum or plasma in the general population. The semi-quantitative and quantitative semi-automated assay is designed for pr (1)
The immunoenzymatic assay is intended for the diagnosis and monitoring of Helicobacter pylori infection using IgG antibodies in human serum or plasma in the general population. The semi-quantitative and quantitative manual assay is designed for profession (1)
The immunoenzymatic assay is intended for the diagnosis and monitoring of Helicobacter pylori infection using IgG antibodies in human serum or plasma in the general population. The semi-quantitative and quantitative semi-automated assay is designed for pr (1)
The immunoenzymatic assay is intended for the diagnosis and monitoring of Toxocara spp. infection using IgG antibodies in human serum or plasma in the general population. The semi-quantitative manual assay is designed for professional use in a laboratory. (1)
The immunoenzymatic assay is intended for the diagnosis and monitoring of Toxocara spp. infection using IgG antibodies in human serum or plasma in the general population. The semi-quantitative semi-automated assay is designed for professional use in a lab (1)
The immunoenzymatic assay is intended for the diagnosis and monitoring of pneumococcal infection using IgG antibodies in human serum or plasma in the general population. The semi-quantitative and quantitative semi-automated assay is designed for professio (1)
The immunoenzymatic assay is intended for the diagnosis and monitoring of tick-borne encephalitis infection using IgG antibodies in human serum (2)
The immunoenzymatic assay is intended for the diagnosis and screening CMV infection using IgG antibodies in human serum (1)
The immunoenzymatic assay is intended for the diagnosis and screening of EBV infection using IgG antibodies to a capsid antigen in human serum (2)
The immunoenzymatic assay is intended for the diagnosis and screening of EBV infection using IgG antibodies to a nuclear antigen in human serum or plasma in the general population. The semi-quantitative and quantitative manual assay is designed for profes (1)
The immunoenzymatic assay is intended for the diagnosis and screening of EBV infection using IgG antibodies to a nuclear antigen in human serum or plasma in the general population. The semi-quantitative and quantitative semi-automated assay is designed fo (1)
The immunoenzymatic assay is intended for the diagnosis and screening of HSV infection using IgG antibodies in human serum (2)
The immunoenzymatic assay is intended for the diagnosis and screening of HSV infection using IgG antibodies in human serum or plasma in the general population. The semi-quantitative manual assay is designed for professional use in a laboratory. (2)
The immunoenzymatic assay is intended for the diagnosis and screening of HSV infection using IgG antibodies in human serum or plasma in the general population. The semi-quantitative semi-automated assay is designed for professional use in a laboratory. (2)
The immunoenzymatic assay is intended for the diagnosis and screening of Toxoplasma gondii infection using IgG antibodies in human serum or plasma in the general population. The semi-quantitative and quantitative manual assay is designed for professional (1)
The immunoenzymatic assay is intended for the diagnosis and screening of Toxoplasma gondii infection using IgG antibodies in human serum or plasma in the general population. The semi-quantitative and quantitative semi-automated assay is designed for profe (1)
The immunoenzymatic assay is intended for the diagnosis and screening of Treponema pallidum infection using total antibodies in human serum or plasma in the general population. The semi-quantitative manual assay is designed for professional use in a labor (1)
The immunoenzymatic assay is intended for the diagnosis and screening of Treponema pallidum infection using total antibodies in human serum or plasma in the general population. The semi-quantitative semi-automated assay is designed for professional use in (1)
The immunoenzymatic assay is intended for the diagnosis of Bordetella parapertussis infection using IgA antibodies in human serum or plasma in the general population. The semi-quantitative manual assay is designed for professional use in a laboratory. (1)
The immunoenzymatic assay is intended for the diagnosis of Bordetella parapertussis infection using IgA antibodies in human serum or plasma in the general population. The semi-quantitative semi-automated assay is designed for professional use in a laborat (1)
The immunoenzymatic assay is intended for the diagnosis of Bordetella parapertussis infection using IgG antibodies in human serum or plasma in the general population. The semi-quantitative manual assay is designed for professional use in a laboratory. (1)
The immunoenzymatic assay is intended for the diagnosis of Bordetella parapertussis infection using IgG antibodies in human serum or plasma in the general population. The semi-quantitative semi-automated assay is designed for professional use in a laborat (1)
The immunoenzymatic assay is intended for the diagnosis of Bordetella parapertussis infection using IgM antibodies in human serum or plasma in the general population. The semi-quantitative manual assay is designed for professional use in a laboratory. (1)
The immunoenzymatic assay is intended for the diagnosis of Bordetella parapertussis infection using IgM antibodies in human serum or plasma in the general population. The semi-quantitative semi-automated assay is designed for professional use in a laborat (1)
The immunoenzymatic assay is intended for the diagnosis of Bordetella pertussis infection using IgA antibodies in human serum or plasma in the general population. The quantitative manual assay is designed for professional use in a laboratory. (1)
The immunoenzymatic assay is intended for the diagnosis of Bordetella pertussis infection using IgA antibodies in human serum or plasma in the general population. The quantitative semi-automated assay is designed for professional use in a laboratory. (1)
The immunoenzymatic assay is intended for the diagnosis of Bordetella pertussis infection using IgM antibodies in human serum or plasma in the general population. The semi-quantitative manual assay is designed for professional use in a laboratory. (1)
The immunoenzymatic assay is intended for the diagnosis of Bordetella pertussis infection using IgM antibodies in human serum or plasma in the general population. The semi-quantitative semi-automated assay is designed for professional use in a laboratory. (1)
The immunoenzymatic assay is intended for the diagnosis of CMV infection using IgA antibodies in human serum (1)
The immunoenzymatic assay is intended for the diagnosis of CMV infection using IgG antibodies in human serum (1)
The immunoenzymatic assay is intended for the diagnosis of CMV infection using IgM antibodies in human serum (1)
The immunoenzymatic assay is intended for the diagnosis of Chlamydia pneumoniae infection using IgA antibodies in human serum or plasma in the general population. The semi-quantitative and quantitative manual assay is designed for professional use in a la (2)
The immunoenzymatic assay is intended for the diagnosis of Chlamydia pneumoniae infection using IgA antibodies in human serum or plasma in the general population. The semi-quantitative and quantitative semi-automated assay is designed for professional use (2)
The immunoenzymatic assay is intended for the diagnosis of Chlamydia pneumoniae infection using IgG antibodies in human serum or plasma in the general population. The semi-quantitative and quantitative manual assay is designed for professional use in a la (2)
The immunoenzymatic assay is intended for the diagnosis of Chlamydia pneumoniae infection using IgG antibodies in human serum or plasma in the general population. The semi-quantitative and quantitative semi-automated assay is designed for professional use (2)
The immunoenzymatic assay is intended for the diagnosis of Chlamydia pneumoniae infection using IgM antibodies in human serum or plasma in the general population. The semi-quantitative manual assay is designed for professional use in a laboratory. (1)
The immunoenzymatic assay is intended for the diagnosis of Chlamydia pneumoniae infection using IgM antibodies in human serum or plasma in the general population. The semi-quantitative semi-automated assay is designed for professional use in a laboratory. (1)
The immunoenzymatic assay is intended for the diagnosis of Chlamydia spp. (LPS) infection using IgA antibodies in human serum or plasma in the general population. The semi-quantitative manual assay is designed for professional use in a laboratory. (1)
The immunoenzymatic assay is intended for the diagnosis of Chlamydia spp. (LPS) infection using IgA antibodies in human serum or plasma in the general population. The semi-quantitative semi-automated assay is designed for professional use in a laboratory. (1)
The immunoenzymatic assay is intended for the diagnosis of Chlamydia spp. (LPS) infection using IgG antibodies in human serum or plasma in the general population. The semi-quantitative manual assay is designed for professional use in a laboratory. (1)
The immunoenzymatic assay is intended for the diagnosis of Chlamydia spp. (LPS) infection using IgG antibodies in human serum or plasma in the general population. The semi-quantitative semi-automated assay is designed for professional use in a laboratory. (1)
The immunoenzymatic assay is intended for the diagnosis of Chlamydia spp. (LPS) infection using IgM antibodies in human serum or plasma in the general population. The semi-quantitative manual assay is designed for professional use in a laboratory. (1)
The immunoenzymatic assay is intended for the diagnosis of Chlamydia spp. (LPS) infection using IgM antibodies in human serum or plasma in the general population. The semi-quantitative semi-automated assay is designed for professional use in a laboratory. (1)
The immunoenzymatic assay is intended for the diagnosis of Chlamydia trachomatis infection using IgA antibodies in human serum or plasma in the general population. The semi-quantitative and quantitative manual assay is designed for professional use in a l (1)
The immunoenzymatic assay is intended for the diagnosis of Chlamydia trachomatis infection using IgA antibodies in human serum or plasma in the general population. The semi-quantitative and quantitative semi-automated assay is designed for professional us (1)
The immunoenzymatic assay is intended for the diagnosis of Chlamydia trachomatis infection using IgG antibodies in human serum or plasma in the general population. The semi-quantitative and quantitative manual assay is designed for professional use in a l (1)
The immunoenzymatic assay is intended for the diagnosis of Chlamydia trachomatis infection using IgG antibodies in human serum or plasma in the general population. The semi-quantitative and quantitative semi-automated assay is designed for professional us (1)
The immunoenzymatic assay is intended for the diagnosis of Chlamydia trachomatis infection using IgM antibodies in human serum or plasma in the general population. The semi-quantitative manual assay is designed for professional use in a laboratory. (1)
The immunoenzymatic assay is intended for the diagnosis of Chlamydia trachomatis infection using IgM antibodies in human serum or plasma in the general population. The semi-quantitative semi-automated assay is designed for professional use in a laboratory (1)
The immunoenzymatic assay is intended for the diagnosis of EBV infection using IgA antibodies to a capsid antigen in human serum (2)
The immunoenzymatic assay is intended for the diagnosis of EBV infection using IgG antibodies to an early antigen in human serum or plasma in the general population. The semi-quantitative manual assay is designed for professional use in a laboratory. (1)
The immunoenzymatic assay is intended for the diagnosis of EBV infection using IgG antibodies to an early antigen in human serum or plasma in the general population. The semi-quantitative semi-automated assay is designed for professional use in a laborato (1)
The immunoenzymatic assay is intended for the diagnosis of EBV infection using IgM antibodies to a capsid antigen in human serum (2)
The immunoenzymatic assay is intended for the diagnosis of EBV infection using IgM antibodies to a nuclear antigen in human serum or plasma in the general population. The semi-quantitative manual assay is designed for professional use in a laboratory. (1)
The immunoenzymatic assay is intended for the diagnosis of EBV infection using IgM antibodies to a nuclear antigen in human serum or plasma in the general population. The semi-quantitative semi-automated assay is designed for professional use in a laborat (1)
The immunoenzymatic assay is intended for the diagnosis of EBV infection using IgM antibodies to an early antigen in human serum or plasma in the general population. The semi-quantitative manual assay is designed for professional use in a laboratory. (1)
The immunoenzymatic assay is intended for the diagnosis of EBV infection using IgM antibodies to an early antigen in human serum or plasma in the general population. The semi-quantitative semi-automated assay is designed for professional use in a laborato (1)
The immunoenzymatic assay is intended for the diagnosis of HSV infection using IgM antibodies in human serum (2)
The immunoenzymatic assay is intended for the diagnosis of HSV infection using IgM antibodies in human serum or plasma in the general population. The semi-quantitative manual assay is designed for professional use in a laboratory. (2)
The immunoenzymatic assay is intended for the diagnosis of HSV infection using IgM antibodies in human serum or plasma in the general population. The semi-quantitative semi-automated assay is designed for professional use in a laboratory. (2)
The immunoenzymatic assay is intended for the diagnosis of Helicobacter pylori infection using IgM antibodies in human serum or plasma in the general population. The semi-quantitative manual assay is designed for professional use in a laboratory. (1)
The immunoenzymatic assay is intended for the diagnosis of IBD using IgA antibodies in human serum or plasma in the general population. The semi-quantitative and quantitative manual assay is designed for professional use in a laboratory. (1)
The immunoenzymatic assay is intended for the diagnosis of IBD using IgA antibodies in human serum or plasma in the general population. The semi-quantitative and quantitative semi-automated assay is designed for professional use in a laboratory. (1)
The immunoenzymatic assay is intended for the diagnosis of IBD using IgG antibodies in human serum or plasma in the general population. The semi-quantitative and quantitative manual assay is designed for professional use in a laboratory. (1)
The immunoenzymatic assay is intended for the diagnosis of IBD using IgG antibodies in human serum or plasma in the general population. The semi-quantitative and quantitative semi-automated assay is designed for professional use in a laboratory. (1)
The immunoenzymatic assay is intended for the diagnosis of Influenza A virus infection using IgA antibodies in human serum or plasma in the general population. The semi-quantitative manual assay is designed for professional use in a laboratory. (1)
The immunoenzymatic assay is intended for the diagnosis of Influenza A virus infection using IgA antibodies in human serum or plasma in the general population. The semi-quantitative semi-automated assay is designed for professional use in a laboratory. (1)
The immunoenzymatic assay is intended for the diagnosis of Influenza A virus infection using IgG antibodies in human serum or plasma in the general population. The semi-quantitative manual assay is designed for professional use in a laboratory. (1)
The immunoenzymatic assay is intended for the diagnosis of Influenza A virus infection using IgG antibodies in human serum or plasma in the general population. The semi-quantitative semi-automated assay is designed for professional use in a laboratory. (1)
The immunoenzymatic assay is intended for the diagnosis of Influenza A virus infection using IgM antibodies in human serum or plasma in the general population. The semi-quantitative manual assay is designed for professional use in a laboratory. (1)
The immunoenzymatic assay is intended for the diagnosis of Influenza A virus infection using IgM antibodies in human serum or plasma in the general population. The semi-quantitative semi-automated assay is designed for professional use in a laboratory. (1)
The immunoenzymatic assay is intended for the diagnosis of Influenza B virus infection using IgA antibodies in human serum or plasma in the general population. The semi-quantitative manual assay is designed for professional use in a laboratory. (1)
The immunoenzymatic assay is intended for the diagnosis of Influenza B virus infection using IgA antibodies in human serum or plasma in the general population. The semi-quantitative semi-automated assay is designed for professional use in a laboratory. (1)
The immunoenzymatic assay is intended for the diagnosis of Influenza B virus infection using IgG antibodies in human serum or plasma in the general population. The semi-quantitative manual assay is designed for professional use in a laboratory. (1)
The immunoenzymatic assay is intended for the diagnosis of Influenza B virus infection using IgG antibodies in human serum or plasma in the general population. The semi-quantitative semi-automated assay is designed for professional use in a laboratory. (1)
The immunoenzymatic assay is intended for the diagnosis of Influenza B virus infection using IgM antibodies in human serum or plasma in the general population. The semi-quantitative manual assay is designed for professional use in a laboratory. (1)
The immunoenzymatic assay is intended for the diagnosis of Influenza B virus infection using IgM antibodies in human serum or plasma in the general population. The semi-quantitative semi-automated assay is designed for professional use in a laboratory. (1)
The immunoenzymatic assay is intended for the diagnosis of Mycoplasma pneumoniae infection using IgA antibodies in human serum or plasma in the general population. The semi-quantitative and quantitative manual assay is designed for professional use in a l (2)
The immunoenzymatic assay is intended for the diagnosis of Mycoplasma pneumoniae infection using IgA antibodies in human serum or plasma in the general population. The semi-quantitative and quantitative semi-automated assay is designed for professional us (2)
The immunoenzymatic assay is intended for the diagnosis of Mycoplasma pneumoniae infection using IgG antibodies in human serum or plasma in the general population. The semi-quantitative and quantitative manual assay is designed for professional use in a l (2)
The immunoenzymatic assay is intended for the diagnosis of Mycoplasma pneumoniae infection using IgG antibodies in human serum or plasma in the general population. The semi-quantitative and quantitative semi-automated assay is designed for professional us (2)
The immunoenzymatic assay is intended for the diagnosis of Mycoplasma pneumoniae infection using IgM antibodies in human serum or plasma in the general population. The semi-quantitative and quantitative manual assay is designed for professional use in a l (2)
The immunoenzymatic assay is intended for the diagnosis of Mycoplasma pneumoniae infection using IgM antibodies in human serum or plasma in the general population. The semi-quantitative and quantitative semi-automated assay is designed for professional us (2)
The immunoenzymatic assay is intended for the diagnosis of RSV infection using IgA antibodies in human serum or plasma in the general population. The semi-quantitative manual assay is designed for professional use in a laboratory. (1)
The immunoenzymatic assay is intended for the diagnosis of RSV infection using IgA antibodies in human serum or plasma in the general population. The semi-quantitative semi-automated assay is designed for professional use in a laboratory. (1)
The immunoenzymatic assay is intended for the diagnosis of RSV infection using IgG antibodies in human serum or plasma in the general population. The semi-quantitative manual assay is designed for professional use in a laboratory. (1)
The immunoenzymatic assay is intended for the diagnosis of RSV infection using IgG antibodies in human serum or plasma in the general population. The semi-quantitative semi-automated assay is designed for professional use in a laboratory. (1)
The immunoenzymatic assay is intended for the diagnosis of RSV infection using IgM antibodies in human serum or plasma in the general population. The semi-quantitative manual assay is designed for professional use in a laboratory. (1)
The immunoenzymatic assay is intended for the diagnosis of RSV infection using IgM antibodies in human serum or plasma in the general population. The semi-quantitative semi-automated assay is designed for professional use in a laboratory. (1)
The immunoenzymatic assay is intended for the diagnosis of Toxocara spp. infection using IgA antibodies in human serum or plasma in the general population. The semi-quantitative manual assay is designed for professional use in a laboratory. (1)
The immunoenzymatic assay is intended for the diagnosis of Toxocara spp. infection using IgA antibodies in human serum or plasma in the general population. The semi-quantitative semi-automated assay is designed for professional use in a laboratory. (1)
The immunoenzymatic assay is intended for the diagnosis of Toxoplasma gondii infection using IgA antibodies in human serum or plasma in the general population. The semi-quantitative manual assay is designed for professional use in a laboratory. (1)
The immunoenzymatic assay is intended for the diagnosis of Toxoplasma gondii infection using IgA antibodies in human serum or plasma in the general population. The semi-quantitative semi-automated assay is designed for professional use in a laboratory. (1)
The immunoenzymatic assay is intended for the diagnosis of Toxoplasma gondii infection using IgE antibodies in human serum or plasma in the general population. The semi-quantitative manual assay is designed for professional use in a laboratory. (1)
The immunoenzymatic assay is intended for the diagnosis of Toxoplasma gondii infection using IgE antibodies in human serum or plasma in the general population. The semi-quantitative semi-automated assay is designed for professional use in a laboratory. (1)
The immunoenzymatic assay is intended for the diagnosis of Toxoplasma gondii infection using IgM antibodies in human serum or plasma in the general population. The semi-quantitative manual assay is designed for professional use in a laboratory. (1)
The immunoenzymatic assay is intended for the diagnosis of Toxoplasma gondii infection using IgM antibodies in human serum or plasma in the general population. The semi-quantitative semi-automated assay is designed for professional use in a laboratory. (1)
The immunoenzymatic assay is intended for the diagnosis of VZV infection using IgA antibodies in human serum (2)
The immunoenzymatic assay is intended for the diagnosis of VZV infection using IgM antibodies in human serum (2)
The immunoenzymatic assay is intended for the diagnosis of Yersinia enterocolitica and Yersinia pseudotuberculosis infections using IgA antibodies in human serum or plasma in the general population. The semi-quantitative manual assay is designed for profe (1)
The immunoenzymatic assay is intended for the diagnosis of Yersinia enterocolitica and Yersinia pseudotuberculosis infections using IgA antibodies in human serum or plasma in the general population. The semi-quantitative semi-automated assay is designed f (1)
The immunoenzymatic assay is intended for the diagnosis of Yersinia enterocolitica and Yersinia pseudotuberculosis infections using IgG antibodies in human serum or plasma in the general population. The semi-quantitative and quantitative manual assay is d (1)
The immunoenzymatic assay is intended for the diagnosis of Yersinia enterocolitica and Yersinia pseudotuberculosis infections using IgG antibodies in human serum or plasma in the general population. The semi-quantitative and quantitative semi-automated as (1)
The immunoenzymatic assay is intended for the diagnosis of Yersinia enterocolitica and Yersinia pseudotuberculosis infections using IgM antibodies in human serum or plasma in the general population. The semi-quantitative manual assay is designed for profe (1)
The immunoenzymatic assay is intended for the diagnosis of Yersinia enterocolitica and Yersinia pseudotuberculosis infections using IgM antibodies in human serum or plasma in the general population. The semi-quantitative semi-automated assay is designed f (1)
The immunoenzymatic assay is intended for the diagnosis of adenovirus infections using IgA antibodies in human serum or plasma in the general population. The semi-quantitative manual assay is designed for professional use in a laboratory. (1)
The immunoenzymatic assay is intended for the diagnosis of adenovirus infections using IgA antibodies in human serum or plasma in the general population. The semi-quantitative semi-automated assay is designed for professional use in a laboratory. (1)
The immunoenzymatic assay is intended for the diagnosis of adenovirus infections using IgG antibodies in human serum or plasma in the general population. The semi-quantitative manual assay is designed for professional use in a laboratory. (1)
The immunoenzymatic assay is intended for the diagnosis of adenovirus infections using IgG antibodies in human serum or plasma in the general population. The semi-quantitative semi-automated assay is designed for professional use in a laboratory. (1)
The immunoenzymatic assay is intended for the diagnosis of adenovirus infections using IgM antibodies in human serum or plasma in the general population. The semi-quantitative manual assay is designed for professional use in a laboratory. (1)
The immunoenzymatic assay is intended for the diagnosis of adenovirus infections using IgM antibodies in human serum or plasma in the general population. The semi-quantitative semi-automated assay is designed for professional use in a laboratory. (1)
The immunoenzymatic assay is intended for the diagnosis of coeliac disease and monitoring of the gluten-free diet effectiveness using IgA antibodies in human serum or plasma in the general population. The semi-quantitative and quantitative manual assay is (1)
The immunoenzymatic assay is intended for the diagnosis of coeliac disease and monitoring of the gluten-free diet effectiveness using IgA antibodies in human serum or plasma in the general population. The semi-quantitative and quantitative semi-automated (1)
The immunoenzymatic assay is intended for the diagnosis of coeliac disease and monitoring of the gluten-free diet effectiveness using IgG antibodies in human serum or plasma in the general population. The semi-quantitative and quantitative manual assay is (1)
The immunoenzymatic assay is intended for the diagnosis of coeliac disease and monitoring of the gluten-free diet effectiveness using IgG antibodies in human serum or plasma in the general population. The semi-quantitative and quantitative semi-automated (1)
The immunoenzymatic assay is intended for the diagnosis of cows milk intolerance using IgA antibodies in human serum or plasma in the general population. The semi-quantitative and quantitative manual assay is designed for professional use in a laboratory. (1)
The immunoenzymatic assay is intended for the diagnosis of cows milk intolerance using IgA antibodies in human serum or plasma in the general population. The semi-quantitative and quantitative semi-automated assay is designed for professional use in a lab (1)
The immunoenzymatic assay is intended for the diagnosis of cows milk intolerance using IgG antibodies in human serum or plasma in the general population. The semi-quantitative and quantitative manual assay is designed for professional use in a laboratory. (1)
The immunoenzymatic assay is intended for the diagnosis of cows milk intolerance using IgG antibodies in human serum or plasma in the general population. The semi-quantitative and quantitative semi-automated assay is designed for professional use in a lab (1)
The immunoenzymatic assay is intended for the diagnosis of cows milk intolerance using IgM antibodies in human serum or plasma in the general population. The semi-quantitative and quantitative manual assay is designed for professional use in a laboratory. (1)
The immunoenzymatic assay is intended for the diagnosis of cows milk intolerance using IgM antibodies in human serum or plasma in the general population. The semi-quantitative and quantitative semi-automated assay is designed for professional use in a lab (1)
The immunoenzymatic assay is intended for the diagnosis of gluten intolerance using IgA antibodies in human serum or plasma in the general population. The semi-quantitative and quantitative manual assay is designed for professional use in a laboratory. (1)
The immunoenzymatic assay is intended for the diagnosis of gluten intolerance using IgA antibodies in human serum or plasma in the general population. The semi-quantitative and quantitative semi-automated assay is designed for professional use in a labora (1)
The immunoenzymatic assay is intended for the diagnosis of gluten intolerance using IgG antibodies in human serum or plasma in the general population. The semi-quantitative and quantitative manual assay is designed for professional use in a laboratory. (1)
The immunoenzymatic assay is intended for the diagnosis of gluten intolerance using IgG antibodies in human serum or plasma in the general population. The semi-quantitative and quantitative semi-automated assay is designed for professional use in a labora (1)
The immunoenzymatic assay is intended for the diagnosis of measles infection using IgM antibodies in human serum or plasma in the general population. The semi-quantitative manual assay is designed for professional use in a laboratory. (1)
The immunoenzymatic assay is intended for the diagnosis of measles infection using IgM antibodies in human serum or plasma in the general population. The semi-quantitative semi-automated assay is designed for professional use in a laboratory. (1)
The immunoenzymatic assay is intended for the diagnosis of mumps infection using IgA antibodies in human serum or plasma in the general population. The semi-quantitative manual assay is designed for professional use in a laboratory. (1)
The immunoenzymatic assay is intended for the diagnosis of mumps infection using IgA antibodies in human serum or plasma in the general population. The semi-quantitative semi-automated assay is designed for professional use in a laboratory. (1)
The immunoenzymatic assay is intended for the diagnosis of mumps infection using IgM antibodies in human serum or plasma in the general population. The semi-quantitative manual assay is designed for professional use in a laboratory. (1)
The immunoenzymatic assay is intended for the diagnosis of mumps infection using IgM antibodies in human serum or plasma in the general population. The semi-quantitative semi-automated assay is designed for professional use in a laboratory. (1)
The immunoenzymatic assay is intended for the diagnosis of parainfluenza virus type 1 (3)
The immunoenzymatic assay is intended for the diagnosis of parainfluenza virus types 1 (3)
The immunoenzymatic assay is intended for the diagnosis of parvovirus B19 infections using IgG antibodies in human serum or plasma in the general population. The semi-quantitative manual assay is designed for professional use in a laboratory. (1)
The immunoenzymatic assay is intended for the diagnosis of parvovirus B19 infections using IgG antibodies in human serum or plasma in the general population. The semi-quantitative semi-automated assay is designed for professional use in a laboratory. (1)
The immunoenzymatic assay is intended for the diagnosis of parvovirus B19 infections using IgM antibodies in human serum or plasma in the general population. The semi-quantitative manual assay is designed for professional use in a laboratory. (1)
The immunoenzymatic assay is intended for the diagnosis of parvovirus B19 infections using IgM antibodies in human serum or plasma in the general population. The semi-quantitative semi-automated assay is designed for professional use in a laboratory. (1)
The immunoenzymatic assay is intended for the diagnosis of rheumatoid arthritis using IgA antibodies to CCP2 in human serum or plasma in the general population. The semi-quantitative and quantitative manual assay is designed for professional use in a labo (1)
The immunoenzymatic assay is intended for the diagnosis of rheumatoid arthritis using IgA antibodies to rheumatoid factor in human serum or plasma in the general population. The semi-quantitative and quantitative manual assay is designed for professional (1)
The immunoenzymatic assay is intended for the diagnosis of rheumatoid arthritis using IgA antibodies to rheumatoid factor in human serum or plasma in the general population. The semi-quantitative and quantitative semi-automated assay is designed for profe (1)
The immunoenzymatic assay is intended for the diagnosis of rheumatoid arthritis using IgG antibodies to CCP2 in human serum or plasma in the general population. The semi-quantitative and quantitative manual assay is designed for professional use in a labo (1)
The immunoenzymatic assay is intended for the diagnosis of rheumatoid arthritis using IgG antibodies to rheumatoid factor in human serum or plasma in the general population. The semi-quantitative and quantitative manual assay is designed for professional (1)
The immunoenzymatic assay is intended for the diagnosis of rheumatoid arthritis using IgG antibodies to rheumatoid factor in human serum or plasma in the general population. The semi-quantitative and quantitative semi-automated assay is designed for profe (1)
The immunoenzymatic assay is intended for the diagnosis of rheumatoid arthritis using IgM antibodies to rheumatoid factor in human serum or plasma in the general population. The semi-quantitative and quantitative manual assay is designed for professional (1)
The immunoenzymatic assay is intended for the diagnosis of rheumatoid arthritis using IgM antibodies to rheumatoid factor in human serum or plasma in the general population. The semi-quantitative and quantitative semi-automated assay is designed for profe (1)
The immunoenzymatic assay is intended for the diagnosis of rubella infection using IgM antibodies in human serum or plasma in the general population. The semi-quantitative manual assay is designed for professional use in a laboratory. (1)
The immunoenzymatic assay is intended for the diagnosis of rubella infection using IgM antibodies in human serum or plasma in the general population. The semi-quantitative semi-automated assay is designed for professional use in a laboratory. (1)
The immunoenzymatic assay is intended for the diagnosis of systemic autoimmune diseases (ENA) using IgG antibodies to Jo-1 antigens in human serum or plasma in the general population. The semi-quantitative and quantitative manual assay is designed for pro (1)
The immunoenzymatic assay is intended for the diagnosis of systemic autoimmune diseases (ENA) using IgG antibodies to Jo-1 antigens in human serum or plasma in the general population. The semi-quantitative and quantitative semi-automated assay is designed (1)
The immunoenzymatic assay is intended for the diagnosis of systemic autoimmune diseases using IgG antibodies to Ro/SS-A antigen in human serum or plasma in the general population. The semi-quantitative and quantitative manual assay is designed for profess (1)
The immunoenzymatic assay is intended for the diagnosis of systemic autoimmune diseases using IgG antibodies to Ro/SS-A antigen in human serum or plasma in the general population. The semi-quantitative and quantitative semi-automated assay is designed for (1)
The immunoenzymatic assay is intended for the diagnosis of systemic autoimmune diseases using IgG antibodies to SS-B/La antigen in human serum or plasma in the general population. The semi-quantitative and quantitative manual assay is designed for profess (1)
The immunoenzymatic assay is intended for the diagnosis of systemic autoimmune diseases using IgG antibodies to SS-B/La antigen in human serum or plasma in the general population. The semi-quantitative and quantitative semi-automated assay is designed for (1)
The immunoenzymatic assay is intended for the diagnosis of systemic autoimmune diseases using IgG antibodies to Scl-70 antigen in human serum or plasma in the general population. The semi-quantitative and quantitative manual assay is designed for professi (1)
The immunoenzymatic assay is intended for the diagnosis of systemic autoimmune diseases using IgG antibodies to Scl-70 antigen in human serum or plasma in the general population. The semi-quantitative and quantitative semi-automated assay is designed for (1)
The immunoenzymatic assay is intended for the diagnosis of systemic autoimmune diseases using IgG antibodies to Sm antigen in human serum or plasma in the general population. The semi-quantitative and quantitative manual assay is designed for professional (1)
The immunoenzymatic assay is intended for the diagnosis of systemic autoimmune diseases using IgG antibodies to Sm antigen in human serum or plasma in the general population. The semi-quantitative and quantitative semi-automated assay is designed for prof (1)
The immunoenzymatic assay is intended for the diagnosis of systemic autoimmune diseases using IgG antibodies to U1RNP antigen in human serum or plasma in the general population. The semi-quantitative and quantitative manual assay is designed for professio (1)
The immunoenzymatic assay is intended for the diagnosis of systemic autoimmune diseases using IgG antibodies to U1RNP antigen in human serum or plasma in the general population. The semi-quantitative and quantitative semi-automated assay is designed for p (1)
The immunoenzymatic assay is intended for the diagnosis of systemic autoimmune diseases using IgG antibodies to dsDNA antigen in human serum or plasma in the general population. The semi-quantitative and quantitative manual assay is designed for professio (1)
The immunoenzymatic assay is intended for the diagnosis of systemic autoimmune diseases using IgG antibodies to dsDNA antigen in human serum or plasma in the general population. The semi-quantitative and quantitative semi-automated assay is designed for p (1)
The immunoenzymatic assay is intended for the diagnosis of systemic autoimmune diseases using IgG antibodies to extractable nuclear antigens and centromere B in human serum or plasma in the general population. The semi-quantitative manual assay is designe (2)
The immunoenzymatic assay is intended for the diagnosis of systemic autoimmune diseases using IgG antibodies to extractable nuclear antigens and centromere B in human serum or plasma in the general population. The semi-quantitative semi-automated assay is (2)
The immunoenzymatic assay is intended for the diagnosis of tick-borne encephalitis infection using IgM antibodies in human serum (2)
The immunoenzymatic assay is intended for the diagnosis rheumatoid arthritis using IgA antibodies to CCP2 in human serum or plasma in the general population. The semi-quantitative and quantitative semi-automated assay is designed for professional use in a (1)
The immunoenzymatic assay is intended for the diagnosis rheumatoid arthritis using IgG antibodies to CCP2 in human serum or plasma in the general population. The semi-quantitative and quantitative semi-automated assay is designed for professional use in a (1)
The immunoenzymatic assay is intended for the monitoring of Tetanus Toxoid using IgG antibodies in human serum or plasma in the general population. The quantitative manual assay is designed for professional use in a laboratory. (1)
The immunoenzymatic assay is intended for the monitoring of Tetanus Toxoid using IgG antibodies in human serum or plasma in the general population. The quantitative semi-automated assay is designed for professional use in a laboratory. (1)
cerebrospinal fluid or synovial fluid in the general population. The qualitative (2)
cerebrospinal fluid or synovial fluid in the general population. The qualitative and semi-quantitativ (2)
cerebrospinal fluid or synovial fluid in the general population. The semi-quantitative and quantitative m (2)
cerebrospinal fluid or synovial fluid in the general population. The semi-quantitative and quantitative s (2)
cerebrospinal fluid or synovial fluid in the general population. The semi-quantitative manual assay is design (4)
cerebrospinal fluid or synovial fluid in the general population. The semi-quantitative semi-au (2)
cerebrospinal fluid or synovial fluid in the general population. The semi-quantitative semi-automated assay i (4)
monitoring and screening of Bordetella pertussis infection using IgG antibodies in human serum or plasma in the general population. The quantitative manual assay is designed for professional use in (1)
monitoring and screening of Bordetella pertussis infection using IgG antibodies in human serum or plasma in the general population. The quantitative semi-automated assay is designed for professional (1)
monitoring and screening of Treponema pallidum infection using IgG antibodies in human serum or plasma in the general population. The semi-quantitative manual assay is designed for professional use (1)
monitoring and screening of Treponema pallidum infection using IgG antibodies in human serum or plasma in the general population. The semi-quantitative semi-automated assay is designed for professio (1)
monitoring and screening of Treponema pallidum infection using IgM antibodies in human serum or plasma in the general population. The semi-quantitative manual assay is designed for professional use (1)
monitoring and screening of Treponema pallidum infection using IgM antibodies in human serum or plasma in the general population. The semi-quantitative semi-automated assay is designed for professio (1)
monitoring and screening of VZV infection using IgG antibodies in human serum (2)
monitoring and screening of measles infection using IgG antibodies in human serum or plasma in the general population. The semi-quantitative and quantitative manual assay is designed for professiona (1)
monitoring and screening of measles infection using IgG antibodies in human serum or plasma in the general population. The semi-quantitative and quantitative semi-automated assay is designed for pro (1)
monitoring and screening of mumps infection using IgG antibodies in human serum or plasma in the general population. The semi-quantitative and quantitative manual assay is designed for professional (1)
monitoring and screening of mumps infection using IgG antibodies in human serum or plasma in the general population. The semi-quantitative and quantitative semi-automated assay is designed for profe (1)
monitoring and screening of rubella infection using IgG antibodies in human serum or plasma in the general population. The semi-quantitative and quantitative manual assay is designed for professiona (1)
monitoring and screening of rubella infection using IgG antibodies in human serum or plasma in the general population. The semi-quantitative and quantitative semi-automated assay is designed for pro (1)
plasma (18)
plasma or cerebrospinal fluid in the general population. The semi-quantitative and quantitative manual assay i (1)
plasma or cerebrospinal fluid in the general population. The semi-quantitative and quantitative manual assay is (1)
plasma or cerebrospinal fluid in the general population. The semi-quantitative and quantitative manual assay is designe (1)
plasma or cerebrospinal fluid in the general population. The semi-quantitative and quantitative manual assay is designed for (1)
plasma or cerebrospinal fluid in the general population. The semi-quantitative and quantitative manual assay is designed for profes (1)
plasma or cerebrospinal fluid in the general population. The semi-quantitative and quantitative manual assay is designed for professional use in (1)
plasma or cerebrospinal fluid in the general population. The semi-quantitative and quantitative semi-automated (1)
plasma or cerebrospinal fluid in the general population. The semi-quantitative and quantitative semi-automated (1)
plasma or cerebrospinal fluid in the general population. The semi-quantitative and quantitative semi-automated assay is (1)
plasma or cerebrospinal fluid in the general population. The semi-quantitative and quantitative semi-automated assay is desig (1)
plasma or cerebrospinal fluid in the general population. The semi-quantitative and quantitative semi-automated assay is designed fo (1)
plasma or cerebrospinal fluid in the general population. The semi-quantitative and quantitative semi-automated assay is designed for p (1)
plasma or cerebrospinal fluid in the general population. The semi-quantitative manual assay is designed for professional use (2)
plasma or cerebrospinal fluid in the general population. The semi-quantitative manual assay is designed for professional use in a laboratory. (5)
plasma or cerebrospinal fluid in the general population. The semi-quantitative semi-automated assay is designed for professio (2)
plasma or cerebrospinal fluid in the general population. The semi-quantitative semi-automated assay is designed for professional use in a laborat (3)
plasma or cerebrospinal fluid in the general population. The semi-quantitative semi-automated assay is designed for professional use in a laboratory (2)
semi-quantitat (2)
semi-quantitative and quantitative automated (1)
semi-quantitative and quantitative automated a (3)
semi-quantitative and quantitative automated assay is designed for p (3)
semi-quantitative and quantitative automated assay is designed for profe (2)
semi-quantitative and quantitative automated assay is designed for profess (3)
semi-quantitative and quantitative automated assay is designed for professio (2)
semi-quantitative and quantitative automated assay is designed for professional u (2)

2mag (80)
3D Bio-Tissues (13)
3Helix (13)
4basebio (27)
A. Johnen Verpackungen (16)
A. Rahf Laborbedarf (4)
ABM (1)
ABP Biosciences (760)
ABclonal (17203)
ADS Biotec Ltd (120)
AHN Biotechnologie (34)
AIT France (410)
ALPCO (385)
ARP American Research Products (7407)
ATAGO (123)
ATTO-TEC (921)
Abbexa (344914)
Abbkine Scientific (3418)
Abcepta (122298)
Abeomics (36156)
Abiel (12)
Abitec (5560)
Abmole Bioscience (13198)
Abnova (98130)
Absolute Antibody (37308)
Accelagen (29)
AcroBiosystems (12825)
Active Motif (3805)
AddexBio (506)
Adooq Bioscience (72532)
Advantec (1302)
Affinity Biosciences (33523)
Agdia EMEA (2270)
Agilent (1)
Agrisera (2626)
Ahlstrom Falun (68)
Ahlstrom-Munksjö (28)
Alan and Co (5)
Albert Kuhn (8)
Almedica (6)
Alpha Diagnostic (13915)
Alpha Laboratories (8)
AlphaScience (3)
AlphaTecSystems (149)
AlphaThera (122)
Altmann Analytik (3)
Amarell (171)
Amcor (4)
Ampersand Biosciences (130)
Amplitech (1)
AnaSpec (2235)
Ananda Devices (2)
Anatrace (1850)
Anogen-Yes Biotech Laboratories (661)
Antibodies Incorporated (3301)
Antibodies.com (186017)
Anton Paar (43)
ApexBio (26034)
Apollo Herkenrath (30)
Apop Biosciences (10)
Aptum Biologics (123)
Arbor Assays (194)
Arctiko (38)
As One (899)
Assay Biotechnology (24650)
Astra Biotech GmbH (48)
Atlas Antibodies (44955)
Aves Labs (381)
Aviva (150812)
Azenta (10)
B-Safety (44)
B. Braun (299)
BANDELIN (604)
BBI Solutions (634)
BD Bioscience (33894)
BINDER GmbH (475)
BIO SB (3246)
BIOMAT (381)
BIOZOL (90)
BMA Biomedicals (1027)
BOCHEM Instrumente GmbH (809)
BR Solution (36)
BRAND (3157)
BRinova (2)
BT Lab (25396)
Bachem (6294)
Barnstead (11)
BartelsRieger (63)
Behr (343)
Beijing Grinder (160)
Bel-Art (228)
BellBrook Labs (314)
Benchmark Scientific (4)
Bergmann Kartonagen (9)
Bierbaum-Proenen (99)
Bio X Cell (1930)
BioActs (711)
BioAssay Systems (290)
BioAssay Works (103)
BioChain Institute (2174)
BioChem Fluidics (447)
BioPorto Diagnostics (340)
BioServUK (426)
BioTeZ (205)
BioVendor (572)
Biochrom (90)
Bioconcept (456)
Biogenex (642)
Biolegend (35786)
Biomatik Corporation (78742)
Biomedica (21)
Bionis (35)
Biorbyt (1717880)
Bioss (428778)
Biosynex (111)
Biosynth (253910)
Biotium (47344)
Bioworld Technology (41059)
BlueGene (99617)
Boettger (40)
Bohemia Cristal (144)
Bohlender (1031)
Boster Bio (153596)
Brady (319)
BrainXell (24)
Buddeberg (61)
BÜCHI (44)
Bürkle (1975)
C. Giese GmbH (52)
CALPRO (10)
CDN (6362)
CETI (639)
CH3 BioSystems (180)
CIL (3242)
Calibre Scientific (2)
Caprico Biotechnologies (4285)
Cedarlane (24821)
Cell Biolabs (634)
Cellcolabs (2)
CeramTec (4)
CertoClav (37)
Chem Service (3790)
Chondrex (917)
ChromaGenix (63)
Chromatrap (868)
Citotest (6)
Clonit (274)
Cloud-Clone (62484)
Cole-Parmer (87)
Columbia Biosciences (292)
Concise Separations (171)
Coolike (7)
Cope (1)
Corning (340)
Cortez Diagnostics (7)
Covalab (10814)
Creative BioMart (48859)
Creative Biolabs (46893)
Cryonos (94)
Crystal (39)
Cusabio (105943)
Cyagen Biosciences Inc. (1014)
Cygnus Technologies (570)
Cytognos (13)
Cytoskeleton (435)
DACOS (10)
DB-Biotech (483)
DCS Diagnostics (179)
DIA.PRO (119)
DIAsource ImmunoAssays (482)
DLAB (3)
DLDEVELOP (30458)
DOSTMANN electronic (120)
DRG Instruments (554)
DWK Life Sciences (2586)
DYMO (130)
Daresbury Proteins (58)
Deutsch und Neumann (451)
Dextra Laboratories (796)
Diba (1341)
Dietmar Knabe (2)
Dojindo (470)
Dominique Dutscher (6)
Dr. Ehrenstorfer (11149)
Dr. Weigert (59)
Dräger (156)
DuPont (28)
ELITech (31)
ELK Biotechnology (25552)
ESCO Lifesciences GmbH (219)
EXBIO (4774)
EXCELITAS (20)
EastCoast Bio (2722)
EastMabBio (282)
Ebba Biotech (189)
Ecoli Dx, s.r.o. (270)
EdgeBio (181)
Elabscience (36169)
Elkay (25)
Elma Schmidbauer GmbH (137)
Encapsula NanoSciences (16)
Endotherm (785)
EnkiLife (29683)
Enzo Life Sciences (11809)
Epredia (236)
Eureka Dry Tech (6)
EuroClone (431)
Eurocell (13)
Everest (6868)
Excelitas Noblelight GmbH (23)
FRYKA (29)
FabGennix (6741)
Fahsig (3)
Firebird Optics (52)
Firefly (915)
Flourochem (1)
Fluorochem (137350)
Focus Biomolecules (1765)
Franz Mensch (22)
Fritsch (297)
Fritz Arndt (10)
Fuller (175)
Fuller Laboratories (12)
Funke Gerber (113)
Future Fields (7)
GA INTERNATIONAL (41)
GVS (52)
Ganterie (4)
Gebra (40)
GeneDireX (241)
GeneTex (48633)
Generic Assays / Medipan (4)
Genesee Scientific (5547)
GenomeMe (1356)
Genscript (14272)
Gentian (8)
GenuIN Biotechnologies (8156)
Gerber Instruments (122)
Gerd Schneider (17)
Gerhard Analytical Systems (2)
Glindemann (8)
Golden Gate Scientific (4)
Gorr Transporttechnik (26)
Grant (391)
Grauer (14)
Green Mountain Antibodies (110)
Greiner Bio-One (76)
Grün-Pumpen (10)
Guangzhou JET Bio-Filtration (280)
HCL (23)
HK-Pack (23)
HORO Dr. Hofmann (4)
HUABIO (10991)
HUMAN (220)
HWS Labortechnik (73)
Hahnemühle (331)
Hailo (5)
Hanhart Chronographen 1882 (15)
HansaBioMed (174)
Hardy Diagnostics (3092)
Harry Gestigkeit (71)
Hartmann (41)
Heathrow Scientific (504)
Hecht Glaswarenfabrik (242)
Heidolph (18)
Heinz Herenz Hamburg (59)
Hellma (199)
HelloBio (1480)
Heraeus Noblelight (69)
Hettich Benelux (93)
Hielscher Ultrasonics (30)
High Purity Standards (1780)
Hilgenberg (57)
Hirschmann Laborgeräte (882)
Honeywell Safety Products (62)
Hospidex (22)
Huber (246)
Huixia (13)
Hycult (1366)
Hülden (17)
Hünersdorff (99)
IBA (200)
IBI Scientific (37)
ICL (1352)
IDCP B.V. (57)
IHC WORLD (634)
IKA (1550)
ION Biosciences (119)
IPHASE Biosciences (931)
IQ Products (472)
ISOHEAT GmbH (161)
ISOLAB (805)
Ideal-tek (69)
Igefa (23)
ImmuQuest (674)
ImmunoChemistry Technologies (512)
ImmunoReagents (1114)
Immunostep (514)
Industrial Physics (47)
Ingenetix (492)
Interstuhl (97)
Invent BioTechnologies (80)
Isca Biochemicals (444)
JUTEC (27)
Jackson ImmunoResearch (3942)
Johann W. Schimmel (11)
Juchheim Laborgeräte (54)
Julabo (456)
KD Scientific (20)
KGW-Isotherm (199)
KINEMATICA GmbH (115)
KactusBio (3865)
Kaiser (2)
Kamiya Biomedical Company (2276)
Karl Hammacher (132)
Kartell LABWARE (636)
Kautex (374)
Kementec (81)
Kerafast (2362)
Kern und Sohn (1538)
Keter Luxembourg (1)
Key Surgical (5)
Kimberly-Clark (84)
Kleinfeld Labortechnik (13)
Klett Kunststofftechnik (12)
Konus Italia Group (22)
Korff (36)
Krishgen Biosystems (28880)
Kroschke (31)
Krüss (58)
Kundert Vario (10)
Köttermann (56)
LAUDA (195)
LEHRICH (19)
LEONHARDY VP (29)
LKT Labs (3156)
LLG Labware (17950)
LMS Consult (2)
LOSCH (1)
La-Pha-Pack (81)
Lab-Club (3550)
Lampire Biological Labs (1830)
Lamy Rheology (91)
Langkavel Office + Lab (24)
Larodan (478)
Leadgene Biomedical (1023)
Lenz Laborglas (1439)
Licefa (1)
Liebherr (119)
LifeSpan Biosciences (1295382)
LifeTein (24)
Linaris (5847)
Linker Industrie-Technik (278)
Liposoma research (100)
List Biological Labs (80)
Ludwig Schneider (407)
Lutz Pumpen (37)
Lybe Scientific (19)
MABTECH (1655)
MAPA (141)
MBL (4789)
MEDITE (3)
MERCK Millipore (21)
MP Biomedicals Germany (6645)
MS Validated Antibodies (582)
Maassen GmbH (17)
Macherey-Nagel (2178)
Manulatex (21)
Marienfeld (161)
Matriks Biotechnology (101)
MaxVision Biosciences (112)
MedNet (12)
MedSchenker (14)
MedchemExpress (237905)
Medix Biochemica (1574)
Memmert (291)
Merck (71)
MetallWarenfabrik Mühlacker (10)
Mettler-Toledo (614)
Micros Produktion (20)
Miele (108)
Mikromol (8136)
Millipore (225)
Mirus Bio (143)
MoBiTec (305)
Molecular Dimension (2112)
Monosan (2458)
Montana Molecular (189)
Morgan Advanced Materials (217)
MyBiosource (2443310)
NABAS (24)
NORMA (75)
NSJ Bioreagents (37697)
NZYtech (3479)
Nabertherm (250)
NanoHelix (186)
NanoTag Biotechnologies (370)
Nanoprobes (231)
Nasco Sampling (49)
NeXtal (381)
NeoBiotechnologies (17250)
Neuromics (2384)
Nexotech (6)
Nitritex (138)
Nordic BioSite (473907)
Nordic Lab (74)
NordicMubio (2793)
Norgen Biotek (676)
Normag (4)
Normax (5)
Normensand (1)
Novelis Deutschland GmbH (16)
OHAUS (960)
OLM Diagnostics (3)
ORI (3)
OSRAM (142)
OZ Biosciences (733)
OaCP (114)
Oasis Diagnostics (14)
Obermeier (7)
Operon (98)
Oxford Biomedical Research (955)
P/S Kunststoffwerke (18)
PBL Assay Science (138)
PGP (39)
PMS TIP TEKNOLOJILERI (45)
PanPath (692)
Peak Scientific (27)
Pfennig Reinigungstechnik GmbH (42)
Phoenix Instrument (37)
Phosphosolutions (775)
Poly-Dtech (76)
PolyScience (88)
PrimerDesign (2588)
ProFoldin (497)
ProSci (45484)
ProSpec-Tany Technogene (7023)
Procell Biotechnology (5002)
ProteinArk (1192)
ProteoGenix (25573)
Qkine (631)
Quantimetrix (39)
RD-Biotech (42)
RJH Biosciences (30)
ROMMELSBACHER (3)
RSG Rostfrei (84)
Randox (2)
Ratiolab (341)
Rauschenberger Innovations (7)
RayBiotech (113105)
Reagecon (3493)
Reagena (34)
Reed Biotech (10548)
Reitenspieß-Bürsten (97)
Reliance Biosciences (3)
Reprocell (247)
Resch Laborglas (32)
Retsch (1047)
Rettberg (38)
RevMAb (462)
Riken Keiki (30)
Rische + Herfurth (47)
Ritter (101)
Roboscreen (181)
Rockland Immunochemicals (12842)
Roland Watzdorf (19)
Rometsch GmbH (17)
Rötzmeier Sicherheitsbehälter (76)
S-Bio (241)
SABEU (59)
SCAT Europe GmbH (422)
SHP (50)
SOCOREX (367)
Saint-Gobain (589)
Salimetrics (57)
Sanyou Bio (1567)
Saropack (1)
Sarstedt (11)
Sartorius (2228)
Sceti (3991)
Scherf Präzision (164)
Schorpp (9)
Schott (66)
Schwan (46)
Schwegmann Filtrations (32)
Schweizer (5)
Schülke und Mayr (17)
Scientific Industries (59)
ScyTek Laboratories (3136)
SeLENOZYME (91)
Selleck (16625)
Semperit (110)
Seramun Diagnostica (33)
SiLI (17)
Sievert (2)
SignalChem (2320)
SignalChem Diagnostics (989)
Sileks (16)
Sino Biological (240905)
Snoltherm (64)
Somagenics (164)
Sonation (4)
Sonepar Deutschland (2)
Sontara (9)
SouthernBiotech (3538)
Spherotech (1017)
Starke Laborbedarf (32)
Starna (25)
Statens Serum Institut (321)
StemBioSys (94)
Sterilin (38)
Surplus Systems (16)
Svanova (38)
Svar Life Science (68)
Synabs (1240)
SÖHNGEN (60)
TENAK (663)
TFA Dostmann (90)
TNC Bio (8)
TOKU-E (2837)
TargetMol (181497)
TdB Labs (286)
TestLine (292)
The Native Antigen Company (1574)
Thermax (14)
Thermo Elect.LED GmbH (1060)
Thies Clima (2)
Thomas Pumpen (48)
Tintometer (543)
Toronto Bioscience (361)
Toronto Research Chemicals (92063)
Trevigen (338)
U-CyTech biosciences (341)
UBPBio, LLC (810)
UCS Diagnostics (1)
US Biological (537820)
USBECK (240)
Umweltanalytik Holbach (12)
Unigloves (298)
Ushio (26)
VIDIA (114)
VITRO (2246)
VMRD (275)
VOLTRONIC (35)
VWR (6)
Vacuubrand (523)
Vazyme Biotech (1001)
Vector Biolabs (536)
Vector Laboratories (2562)
VectorBuilder (537)
Velp Scientifica (257)
Vikan (90)
Virax Biolabs (94)
ViroStat (1323)
Virusys (160)
Vitro Biopharma (21)
VmP (8)
WEDO (38)
Waldmann (2)
Waring (18)
Water-i.d. (110)
Werner Arzneimittel (7)
Wilhelm Schröder (9)
Wolf Maschinenbau AG (4)
Württ. Drahtwarenfabrik (68)
Württembergische Allplastik (14)
Xylem Analytics (759)
Yashraj Biotechnology (55)
YouSeq (684)
ZIRBUS technology (62)
ZVG Zellstoffvertrieb (49)
ZellBio (154)
Zytomed Systems (7714)
asecos (109)
baseclick (257)
biomedis (7)
dianova (1604)
edding (147)
eutecma (20)
eversyn (8)
helo (4)
highQu (125)
in-EV (37)
interscience (95)
magtivio (226)
messner emtronic (21)
nanoComposix (549)
nanoimmunotech (214)
peptides and elephants (1871)
proQuarz (49)
reddot Biotech (34636)
schuett-biotec (234)
stakpure (98)
tec-lab (17)
tesa (6)
trenzyme (194)
uvex (424)

BIOZOL Catalog Number: BVD-ADA096

EIA Adenovirus IgA

Manufacturer: TestLine
Application: The immunoenzymatic assay is intended for the diagnosis of adenovirus infections using IgA antibodies in human serum or plasma in the general population. The semi-quantitative manual assay is designed for professional use in a laboratory.
Size: 96 tests
Category: Human Diagnostics

BIOZOL Catalog Number: BVD-ADG096

EIA Adenovirus IgG

Manufacturer: TestLine
Application: The immunoenzymatic assay is intended for the diagnosis of adenovirus infections using IgG antibodies in human serum or plasma in the general population. The semi-quantitative manual assay is designed for professional use in a laboratory.
Size: 96 tests
Category: Human Diagnostics

BIOZOL Catalog Number: BVD-ADM096

EIA Adenovirus IgM

Manufacturer: TestLine
Application: The immunoenzymatic assay is intended for the diagnosis of adenovirus infections using IgM antibodies in human serum or plasma in the general population. The semi-quantitative manual assay is designed for professional use in a laboratory.
Size: 96 tests
Category: Human Diagnostics

BIOZOL Catalog Number: BVD-ANAL20

BLOT-LINE ANA

Manufacturer: TestLine
Application: The immunoblot assay is intended for the diagnosis of systemic autoimmune diseases using IgG antibodies to nuclear antigens in human serum or plasma in the general population. The qualitative and semi-quantitative manual assay is designed for professional
Size: 20 tests
Category: Human Diagnostics

BIOZOL Catalog Number: BVD-ANC3L20

BLOT-LINE ANCA-3

Manufacturer: TestLine
Application: The immunoblot assay is intended for the diagnosis of systemic autoimmune diseases using IgG antibodies to neutrophil cytoplasm and GBM in human serum or plasma in the general population. The qualitative and semi-quantitative manual assay is designed for
Size: 20 tests
Category: Human Diagnostics

BIOZOL Catalog Number: BVD-APGL10

BLOT-LINE Anaplasma IgG

Manufacturer: TestLine
Application: The immunoblot assay is intended for the diagnosis of Anaplasma phagocytophilum infection using IgG antibodies in human serum or plasma in the general population. The qualitative and semi-quantitative manual assay is designed for professional use in a lab
Size: 10 tests
Category: Human Diagnostics

BIOZOL Catalog Number: BVD-APML10

BLOT-LINE Anaplasma IgM

Manufacturer: TestLine
Application: The immunoblot assay is intended for the diagnosis of Anaplasma phagocytophilum infection using IgM antibodies in human serum or plasma in the general population. The qualitative and semi-quantitative manual assay is designed for professional use in a lab
Size: 10 tests
Category: Human Diagnostics

BIOZOL Catalog Number: BVD-BAGVD2

EIA Borrelia afzelii VlsE IgG (192)

Manufacturer: TestLine
Application: The immunoenzymatic assay is intended for the diagnosis and monitoring of Borrelia afzelii infection using IgG antibodies in human serum, plasma, cerebrospinal fluid or synovial fluid in the general population. The semi-quantitative manual assay is design
Size: 192 tests
Category: Human Diagnostics

BIOZOL Catalog Number: BVD-BAM192

EIA Borrelia afzelii IgM (192)

Manufacturer: TestLine
Application: The immunoenzymatic assay is intended for the diagnosis and monitoring of Borrelia afzelii infection using IgM antibodies in human serum, plasma, cerebrospinal fluid or synovial fluid in the general population. The semi-quantitative manual assay is design
Size: 192 tests
Category: Human Diagnostics

BIOZOL Catalog Number: BVD-BGGVD2

EIA Borrelia garinii VlsE IgG (192)

Manufacturer: TestLine
Application: The immunoenzymatic assay is intended for the diagnosis and monitoring of Borrelia garinii infection using IgG antibodies in human serum, plasma, cerebrospinal fluid or synovial fluid in the general population. The semi-quantitative manual assay is design
Size: 192 tests
Category: Human Diagnostics